The company returned to growth after its business contracted in 2023 and 2024.
The 2025 profit topped RON19 million, after a 12% advance.
The company’s number of employees remained flat at around 235.
(English version by Catalina Apostoiu)
Drug plant Fiterman Pharma, owned by Fiterman family of Iasi, reached almost RON180 million turnover from production in 2025, slightly up from 2024.